CA - Zymeworks ZW171 IND for mesothelin-expressing cancers cleared by FDA
2024-06-17 14:49:47 ET
More on Zymeworks
- Buy Zymeworks Pioneering Cancer Treatments: Zanidatamab's Promising Data
- Zymeworks shares sink after company removes CFO Christopher Astle
- Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript
- Zymeworks Q1 2024 Earnings Preview
- Seeking Alpha's Quant Rating on Zymeworks